2 October 2015
Long-term realism and cost-effectiveness: primary prevention in combatting cancer and associated inequalities worldwide
The global figure of 14 million new cancer cases in 2012 is projected to rise to almost 22 million by 2030. While the overheads of cancer care are set to rapidly increase in all countries worldwide irrespective of income, the limited resources to treat and manage the growing number of cancer patients in low- and middle-income countries threaten national economic development. A new article published in the
Journal of the National Cancer Institute assesses current data, collated in the recent second edition of
The Cancer Atlas by the American Cancer Society and the International Agency for Research on Cancer (IARC), to show that a substantial proportion of cancers are preventable and that prevention is cost-effective.
Long-term realism and cost-effectiveness: primary prevention in combatting cancer and associated inequalities worldwide
Bray F, Jemal A, Torre LA, Forman F, and Vineis P
Journal of the National Cancer Institute 2015, http://dx.doi.org/10.1093/jnci/djv273
Read article
IARC hosts WHO UCN team
The International Agency for Research on Cancer (IARC) hosted senior personnel of the World Healt...
15.04.2024
Read more
Advisory Group recommendations on priorities for the IARC Monographs
The results of the recent meeting of the Advisory Group to Recommend Priorities for the IARC Mono...
12.04.2024
Read more
IARC Biobank obtains GIS IBiSA label
The biobank of the International Agency for Research on Cancer (IARC) has been granted one of six...
10.04.2024
Read more